Australia markets closed

Novavax, Inc. (NVAX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.93+0.34 (+5.16%)
At close: 04:00PM EDT
6.97 +0.04 (+0.58%)
After hours: 07:59PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts5555
Avg. Estimate-3.42-2.06-6.18-2.8
Low estimate-3.86-2.67-8.46-6.7
High estimate-3.05-1.57-1.442.39
Year ago EPS2.56-6.53-8.42-6.18
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts5555
Avg. Estimate95.61M186.07M897.6M905.62M
Low estimate70M113.3M552.5M447M
High estimate124.46M239.74M1.21B1.48B
Year ago sales703.97M185.93M1.98B897.6M
Sales growth (year/est)-86.40%0.10%-54.70%0.90%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS2.695.51.57-0.92
Actual EPS2.56-6.53-2.15-2.28
Difference-0.13-12.03-3.72-1.36
Surprise %-4.80%-218.70%-236.90%-147.80%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate-3.42-2.06-6.18-2.8
7 days ago-3.42-2.06-6.18-2.8
30 days ago-1.5-1.29-5.01-1.89
60 days ago-1.5-1.36-5.510.46
90 days ago-1.48-1.25-5.310.46
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesNVAXIndustrySector(s)S&P 500
Current qtr.-233.60%N/AN/AN/A
Next qtr.68.50%N/AN/AN/A
Current year26.60%N/AN/AN/A
Next year54.70%N/AN/AN/A
Next 5 years (per annum)-69.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A